Regnum Corp Stock Analysis
| RGMP Stock | USD 0.0001 0.00 0.00% |
Regnum Corp is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Regnum Corp pink sheet analysis is to determine its intrinsic value, which is an estimate of what Regnum Corp is worth, separate from its market price. There are two main types of Regnum Corp's stock analysis: fundamental analysis and technical analysis.
The Regnum Corp pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Regnum |
Regnum Pink Sheet Analysis Notes
About 99.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.02. Regnum Corp had not issued any dividends in recent years. Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab , a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. REGNUM CORP operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.The quote for Regnum Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Regnum Corp contact Anne Kirby at 877 313 2232 or learn more at http://www.regnumcorp.com.Regnum Corp Investment Alerts
| Regnum Corp generated a negative expected return over the last 90 days | |
| Regnum Corp has some characteristics of a very speculative penny stock | |
| Regnum Corp has a very high chance of going through financial distress in the upcoming years | |
| Regnum Corp currently holds 1.53 M in liabilities. Regnum Corp has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Regnum Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Regnum Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Regnum Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Regnum to invest in growth at high rates of return. When we think about Regnum Corp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 9 K. Net Loss for the year was (117.67 K) with profit before overhead, payroll, taxes, and interest of 6.77 K. | |
| Regnum Corp currently holds about 1.26 M in cash with (3.67 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 99.0% of the company outstanding shares are owned by corporate insiders |
Regnum Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regnum Corp's market, we take the total number of its shares issued and multiply it by Regnum Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Regnum Corp, as well as the relationship between them.Regnum Corp Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to Regnum Corp changes than the simple moving average.
Regnum Corp Outstanding Bonds
Regnum Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Regnum Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Regnum bonds can be classified according to their maturity, which is the date when Regnum Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US75913MAA71 Corp BondUS75913MAA71 | View | |
| REGIONS FINL P Corp BondUS7591EPAE09 | View | |
| RF 18 12 AUG 28 Corp BondUS7591EPAT77 | View |
About Regnum Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Regnum Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Regnum shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Regnum Corp. By using and applying Regnum Pink Sheet analysis, traders can create a robust methodology for identifying Regnum entry and exit points for their positions.
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab , a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. REGNUM CORP operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Regnum Corp to your portfolios without increasing risk or reducing expected return.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Additional Tools for Regnum Pink Sheet Analysis
When running Regnum Corp's price analysis, check to measure Regnum Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regnum Corp is operating at the current time. Most of Regnum Corp's value examination focuses on studying past and present price action to predict the probability of Regnum Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regnum Corp's price. Additionally, you may evaluate how the addition of Regnum Corp to your portfolios can decrease your overall portfolio volatility.